Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial

INTRODUCTION: Immune thrombocytopenia (ITP) is an autoimmune condition that may cause thrombocytopenia-related bleeding. Current first-line ITP treatment is with high-dose corticosteroids but frequent side effects, heterogeneous responses and high relapse rates are significant problems with only 20%...

Descripción completa

Detalles Bibliográficos
Autores principales: Pell, Julie, Greenwood, Rosemary, Ingram, Jenny, Wale, Katherine, Thomas, Ian, Kandiyali, Rebecca, Mumford, Andrew, Dick, Andrew, Bagot, Catherine, Cooper, Nichola, Hill, Quentin, Bradbury, Charlotte Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196935/
https://www.ncbi.nlm.nih.gov/pubmed/30341143
http://dx.doi.org/10.1136/bmjopen-2018-024427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196935/
https://www.ncbi.nlm.nih.gov/pubmed/30341143
http://dx.doi.org/10.1136/bmjopen-2018-024427

Ejemplares similares